Members of Thai Lepto-AKI study group include:
Nattachai Srisawat, M.D.(Lead author), Kearkiat Praditpornsilpa, M.D., Sadudee Peerapornratana, M.D., Passisd Loahaveeravat, M.D., Nattachai Suwachittanont, M.D., Thaksa-on Wirotwan M.D., Chayanat Phonork, M.S., Sarinya Kumpunya, B.A., Khajohn Tiranathanagul, M.D., Somchai Eiam-ong, M.D., and Kriang Tungsanga, M.D., Natavudh Townamchai, M.D., from Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Bangkok, Thailand,
Kanitha Patarakul, M.D., Chintana Chirathaworn, Ph.D. from Department of Microbiology and Immunology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;
Malee Techapornrung, M.D from Prapokklao hospital, Chantaburi, Thailand;
Tinnapop Daraswang, M.D. from Krasang hospital, Buriram, Thailand;
Theerapon Sukmark, M.D. from Thungsong hospital, Nakhon Si Thammarat, Thailand;
Kamol Khositrangsikun, M.D. from Maharaj Nakhon Si Thammarat hospital, Nakhon Si Thammarat, Thailand;
Apinya Fakthongyoo, M.D. from Uttaradit hospital, Uttaradit, Thailand;
Petchdee Oranrigsupak, M.D. from Nan hospital, Nan, Thailand;
LaksamonPraderm, M.D. from Roiet hospital, Roiet, Thailand;
Ummarit Suwattanasilpa, M.D. from Mahasarakarm hospital, Mahasarakarm, Thailand;
Visith Sitprija, M.D. from Queen Saovabha Memorial Institute, Thai Red Cross, Thailand;
John A. Kellum, M.D. from The CRISMA Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, United States.